Medication info
Telminova Tablet 40/10mg

Telminova Tablet 40/10mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.87mg / 1 tabletTelmisartan›40mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
White or off-white oval tablets
Packaging
30 tablets/box [10 tablets/blister x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 201605785 · Approved 2016.09.30 · Insurance code 649604650

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). It is recommended to adjust the dose using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty managing blood pressure with monotherapy of Telmisartan or Amlodipine. It helps to lower blood pressure reliably and aids in blood pressure management.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). It is recommended to adjust the dose using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. Individuals with allergies to this medication's active ingredients or similar drug classes, severe liver impairment, certain heart diseases, pregnant women, nursing mothers, and individuals with specific kidney diseases should avoid taking this medication. Patients with weak liver or kidney function, patients with heart valve diseases, gastrointestinal diseases, and the elderly should use this medication with more caution and follow the physician's guidance closely. Common side effects during the use of this medication include dizziness, edema, and low blood pressure. In severe cases, fainting or heart problems may occur; therefore, immediate consultation with a healthcare professional is necessary if abnormal symptoms occur. Patients with excessively low blood pressure or kidney function issues should regularly check their blood pressure and undergo blood tests to monitor kidney function and electrolyte status. This medication may interact with other medications; if currently taking other medications, it is essential to inform and consult a physician or pharmacist. If planning to become pregnant or confirmed pregnant, it is advised to discontinue this medication as soon as possible and switch to another safer antihypertensive drug. Nursing mothers are also advised not to take this medication, and decisions should be made after consulting with a physician if necessary. Due to dizziness or drowsiness, caution is required when driving or operating machinery, and activity should be limited if such symptoms occur after taking this medication. In case of overdose, symptoms such as low blood pressure, arrhythmias, and dizziness may arise; therefore, care must be taken not to exceed the recommended dosage, and immediate contact with a medical professional is advised if unusual symptoms occur. The safety and efficacy of this medication in children have not been adequately established, so it is recommended that patients under 18 years of age do not take it. When storing this medication, keep it out of the reach of children and preserve it in its original packaging while ensuring it does not get damp.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormality
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver damage
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • elevated serum uric acid
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light in. Additionally, it is important to keep the medication at room temperature, between 1 degree and 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

White or off-white oval tablets

Package unit

30 tablets/box [10 tablets/blister x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.